Market Tracker

12/19 11:01pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

24.49
Data as of Dec 19
 +0.59 / +2.47%
Today’s Change
8.99
Today|||52-Week Range
24.86
+162.21%
Year-to-Date

Today’s Trading

Previous close23.90
Today’s open23.76
Day’s range23.22 - 24.86
Volume2,188,403
Average volume (3 months)669,021
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-18.12%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book13.70

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+1.73+3.15%
CLVSClovis Oncology Inc-1.04-1.80%
MDCOMedicines Co+0.27+1.00%
AUXLAuxilium Pharmaceuti...+0.68+1.98%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateFebruary 4, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts